Skip to content

The acute cycling exercise-induced inflammatory response on those with gastrointestinal disorders and healthy controls.

Effects of acute cycling, continuous vs interval, on L-1 receptor antagonist, monocyte chemoattractant protein-1 and interleukin-17 in gastrointestinal disorders and healthy controls - a randomised crossover trial.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12626000635369
Enrollment
22
Registered
2026-05-26
Start date
2022-09-05
Completion date
2023-09-04
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Despite the potential for exercise as an effective therapeutic approach for people with gastrointestinal (GI) disorders, often studies on exercise and GI disorders explore the patient’s well-being and disease activity without objective inflammatory markers. To strengthen the development of exercise as a management strategy, the acute exercise-induced response and interaction with GI disorders warrants investigation. Therefore, the purpose of this study was to investigate the acute exercise-induced inflammatory response in individuals with GI disorders; specifically, IBD and IBS, and compare these responses to healthy controls (HC). We hypothesis that people with GI disorders will elicit an acute anti-inflammatory response with an increase in the post exercise period (immediately and 2h post).

Interventions

This study investigates the acute exercise-induced inflammatory response for a gastrointestinal group (GI), specifically inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), compared to healthy controls (HC), and further compared moderate-intensity continuous exercise (MICE) with high/low-intensity interval exercise (HIIE) as a randomised crossover protocol. Prior to enrolment into the study, all participants were required to complete the Adult Pre-Exercise Screening System (AP

This study investigates the acute exercise-induced inflammatory response for a gastrointestinal group (GI), specifically inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), compared to healthy controls (HC), and further compared moderate-intensity continuous exercise (MICE) with high/low-intensity interval exercise (HIIE) as a randomised crossover protocol. Prior to enrolment into the study, all participants were required to complete the Adult Pre-Exercise Screening System (APSS), a health history questionnaire, and the Depression, Anxiety, and Stress Scales-21 (DASS-21). Participants in the GI group completed an additional disease-specific questionnaire, either Harvey-Bradshaw Index (HBI), the Simple Clinical Colitis Activity Index (SCCAI) or the IBS-Symptom Severity Scale (IBS-SSS) for CD, UC, and IBS, respectively. Following pre-screening, and if satisfying the inclusion criteria, informed consent was obtained, and participants were enrolled into the study. Participants then completed an initial familiarisation and baseline testing session, which included measures of anthropometry, dual-energy x-ray absorptiometry (DEXA) scan, a graded exercise test (GXT), and a fasted blood sample. After a 7 day (d) rest, participants completed two exercise protocols in a randomised, counter-balanced order separated by 7 d. For each testing session a fasted pre-exercise venous blood sample was taken and then immediately (0min), 2h and 24h post exercise. The exercise protocol, described subsequently, was 35 min in duration. The participants remained fasted throughout the exercise protocol and for the 2hr post exercise blood sample. Water was permitted throughout the fast, including throughout the exercise protocol and post-exercise, no food was permitted 8 hours prior to the exercise intervention. Each participant was randomly allocated an acute exercise protocol that consisted of a 35min continuous stationary cycle ergometry (Monark 828E, Monark Exercise AB, Varburg, Sweden). The two exercise protocols were either moderate-intensity continuous exercise (MICE) or alternating high- and low- intensity interval exercise (HIIE). MICE was performed at 65% of VO2peak and HIIE was performed at a ratio of 2:3 (120s at 50% VO2peak: 180s at 80% VO2peak). The workload was calculated as a percentage of power output achieved in the GXT, then converted into kilopond units and set as a fixed workload of the MICE and alternating workload for the HIIE. Further, telemetry-based HR and RPE (Borg CR10 scale) were recorded every 5min throughout the protocol. Intravenous blood sampling was drawn at pre-exercise, immediately- (0min), 2h- and 24h- post cycling intervention. Gastrointestinal symptoms were individually monitored and reported during, post- and 24h after exercise. Following another 7 d rest period, the participants arrived at the laboratory to complete the second exercise protocol. Each intervention was completed in Charles Sturt University Exercise Physiology Laboratory by the principal investigator who is an Exercise Sports Science Australia (ESSA) Accredited Exercise Scientist (AES) and was a PhD student at the time. They also have their Certificate in Pathology for venous blood collection. Each session was 1 on 1 between the participants and principal investigator. Direct supervision was provided by the principal investigator and would monitor exercise adherence by recording HR and RPE every 5 minutes, and changing resistance when required throughout the HIIE. This research was approved by the institutional ethic and biosafety committee.

Sponsors

Charles Sturt University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Inflammatory Bowel Disease Group: Diagnosis and clearance for inflammatory bowel disease was by a general practitioner (GP) or specialist before participation in the study. Irritable Bowel Syndrome Group: Irritable bowel syndrome participants were screened for eligibility according to the Rome IV criteria. Healthy Control Group: Healthy control participants were free from cardiovascular disease, Type 2 diabetes mellitus, any form of cancer, thyroid disease, stroke, head trauma, epilepsy, multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, other neuromotor disorders, and any other diseases or conditions associated with systemic inflammatory responses.

Exclusion criteria

All participants were excluded if they were pregnant or breast-feeding. Healthy controls were excluded if they have any of the following: cardiovascular disease, Type 2 diabetes mellitus, any form of cancer, thyroid disease, stroke, head trauma, epilepsy, multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, other neuromotor disorders, and any other diseases or conditions associated with systemic inflammatory responses.

Outcome results

None listed

Source: ANZCTR · Data processed: Jul 3, 2026